HS
HighVista Strategies’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-41,194
| Closed | -$416K | – | 117 |
|
|
2022
Q4 | $416K | Sell |
41,194
-70,351
| -63% | -$710K | 0.25% | 80 |
|
|
2022
Q3 | $2.5M | Sell |
111,545
-7,233
| -6% | -$162K | 1.43% | 26 |
|
|
2022
Q2 | $2.94M | Buy |
118,778
+54,113
| +84% | +$1.34M | 1.78% | 18 |
|
|
2022
Q1 | $2.51M | Buy |
64,665
+41,584
| +180% | +$1.61M | 1.59% | 17 |
|
|
2021
Q4 | $1.35M | Buy |
23,081
+5,947
| +35% | +$348K | 1.07% | 29 |
|
|
2021
Q3 | $1.02M | Buy |
17,134
+6,006
| +54% | +$356K | 0.67% | 51 |
|
|
2021
Q2 | $966K | Buy |
+11,128
| New | +$966K | 0.69% | 23 |
|
|
2020
Q4 | – | Sell |
-13,807
| Closed | -$552K | – | 125 |
|
|
2020
Q3 | $552K | Buy |
13,807
+1,344
| +11% | +$53.7K | 0.4% | 39 |
|
|
2020
Q2 | $428K | Buy |
+12,463
| New | +$428K | 0.35% | 43 |
|